GIANNINI, CATERINA
 Distribuzione geografica
Continente #
AS - Asia 7.108
NA - Nord America 6.867
EU - Europa 3.183
SA - Sud America 438
AF - Africa 264
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.880
Nazione #
US - Stati Uniti d'America 6.779
SG - Singapore 2.255
CN - Cina 1.509
VN - Vietnam 1.448
HK - Hong Kong 739
DE - Germania 738
GB - Regno Unito 547
IT - Italia 423
IN - India 408
FR - Francia 320
BR - Brasile 306
SE - Svezia 260
RU - Federazione Russa 217
JP - Giappone 183
KR - Corea 175
IE - Irlanda 173
BD - Bangladesh 127
FI - Finlandia 122
TG - Togo 108
NL - Olanda 97
AT - Austria 87
AR - Argentina 60
ZA - Sudafrica 57
CH - Svizzera 41
CA - Canada 38
ID - Indonesia 37
ES - Italia 31
CI - Costa d'Avorio 30
IQ - Iraq 29
UA - Ucraina 29
MX - Messico 27
SC - Seychelles 25
PK - Pakistan 23
PH - Filippine 22
TR - Turchia 21
BG - Bulgaria 20
TH - Thailandia 20
EC - Ecuador 18
BE - Belgio 17
PL - Polonia 16
AU - Australia 15
CL - Cile 14
SA - Arabia Saudita 14
MY - Malesia 13
CO - Colombia 12
TW - Taiwan 12
IL - Israele 10
JO - Giordania 10
RO - Romania 10
UZ - Uzbekistan 9
EG - Egitto 8
GR - Grecia 8
KE - Kenya 8
LB - Libano 8
MA - Marocco 8
PE - Perù 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
ET - Etiopia 6
KZ - Kazakistan 6
TN - Tunisia 6
PY - Paraguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
HN - Honduras 4
IR - Iran 4
MD - Moldavia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
HU - Ungheria 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
BH - Bahrain 2
BZ - Belize 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
LT - Lituania 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SR - Suriname 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
Totale 17.870
Città #
Singapore 1.544
Hong Kong 723
Chandler 693
Ashburn 614
San Jose 578
Santa Clara 467
Southend 434
Fairfield 395
Hefei 338
Ho Chi Minh City 308
Hanoi 301
Princeton 279
Wilmington 241
Dong Ket 239
Houston 232
Woodbridge 230
Beijing 217
Boardman 193
Seattle 189
Seoul 173
Dublin 172
Tokyo 161
Ann Arbor 160
Lauterbourg 146
Cambridge 142
Lomé 108
Berlin 106
Helsinki 106
Westminster 99
Dallas 94
Los Angeles 94
Des Moines 83
Council Bluffs 71
New York 65
Redondo Beach 64
Nuremberg 62
Buffalo 56
Jinan 54
Milan 54
Bologna 53
London 50
Haiphong 38
Kerkrade 38
Vienna 38
Bengaluru 36
Shanghai 35
Chicago 33
Falls Church 33
San Diego 33
São Paulo 33
Da Nang 32
Yubileyny 32
Frankfurt am Main 31
Pune 31
Abidjan 30
Bern 30
Phoenix 28
Changsha 27
Redwood City 27
Shenzhen 26
Jakarta 25
Nanjing 22
Guangzhou 21
Zhengzhou 21
Rome 19
Antioch 18
Can Tho 18
Columbus 18
Naples 18
Orlando 18
Sofia 18
Hangzhou 17
Baghdad 16
Medford 16
Munich 16
Paris 16
Quận Bình Thạnh 16
Hải Dương 15
Rochester 15
Taiyuan 15
Barcelona 14
Bühl 14
Norwalk 14
San Francisco 14
Brussels 13
Hanover 13
Tongling 13
Wuhan 13
Bangkok 12
Biên Hòa 12
Mülheim 12
Shenyang 12
Amsterdam 11
Atlanta 11
Bến Tre 11
Indianapolis 11
Wenzhou 11
Amman 10
Chennai 10
Fuzhou 10
Totale 11.598
Nome #
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial 296
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 291
Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre 239
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 205
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT 203
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas 200
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma 197
24-Year-Old Woman with Recent Onset Back Pain 195
Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it? 192
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance) 187
Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients 185
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13 175
Failure of human rhombic lip differentiation underlies medulloblastoma formation 168
Heterogeneity within the PF-EPN-B ependymoma subgroup 162
2016 updates to the WHO brain tumor classification system: What the radiologist needs to know 160
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading 152
Intertumoral Heterogeneity within Medulloblastoma Subgroups 150
Primary central nervous system vasculitis associated with lymphoma 148
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3 148
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma 146
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma 143
Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts 142
The transcriptional landscape of Shh medulloblastoma 141
Adult Medulloblastoma: Updates on Current Management and Future Perspectives 141
Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort 139
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading 139
Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors 138
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations 137
A 21-year-old woman with multiple cancers and a new brain lesion 137
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation 135
Advances in multidisciplinary therapy for meningiomas 134
A Comprehensive Study of Spindle Cell Oncocytoma of the Pituitary Gland: Series of 6 Cases and Meta-Analysis of 85 Cases 134
Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases 133
Rare primary non-neuroendocrine tumours of the sella 132
Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia 131
Anaplastic Ependymoma and Posterior Fossa Grouping in a Patient With H3K27ME3 Loss of Expression but Chromosomal Imbalance 131
Chordoma of the corpus callosum: Case report 130
A tribute to our case of the month and a warm welcome to "under your microscope" 127
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma 127
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility 127
A pediatric intra-axial malignant smarcb1-deficient desmo-plastic tumor arising in meningioangiomatosis 126
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas 125
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis 125
Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration 123
Inflammatory cortical demyelination in early multiple sclerosis 123
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis 123
Life after surgical resection of a meningioma: A prospective cross-sectional study evaluating health-related quality of life 121
PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases 120
Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young 120
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 120
Adult primary central nervous system vasculitis treatment and course: Analysis of one hundred sixty-three patients 120
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis 120
SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNA 118
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC) 118
Bilateral generalized polymicrogyria (BGP) - A distinct syndrome of cortical malformation 118
Adult patients with supratentorial pilocytic astrocytoma: Long-term follow-up of ospective multicenter clinical trial NCCTG-867251 (alliance) 117
Telomere alterations in neurofibromatosis type 1-associated solid tumors 116
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas 116
Can intraneural perineuriomas occur intradurally? An anatomic perspective 115
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas 114
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation 114
Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association 112
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism 112
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872 112
Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience 112
Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions 112
Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: Case report 111
The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma 111
Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? 110
Venous congestive myelopathy: a mimic of neoplasia 110
Low-grade fibromyxoid sarcoma arising within the median nerve 108
Imaging and diagnostic advances for intracranial meningiomas 108
DNA methylation profiling to predict recurrence risk in meningioma: Development and validation of a nomogram to optimize clinical management 108
Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior 107
Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients 106
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma 105
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) 105
Glioneuronal Heterotopia Presenting as Cerebellopontine Angle Tumor of Cranial Nerve VIII 104
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant 104
Case-based review: Primary central nervous system lymphoma 103
Brachial plexus lipomatosis with perineurial pseudoonion bulb formation: Result of a mosaic PIK3CA mutation in the para???axial mesoderm state 102
An Update of the Mayo Clinic Cohort of Patients with Adult Primary Central Nervous System Vasculitis 102
Case-based review: Newly diagnosed glioblastoma 102
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 101
Molecular profiling of long-term IDH-wildtype glioblastoma survivors 100
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis 99
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme 98
A revised diagnostic classification of canine glioma: Towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma 98
Pilocytic astrocytoma: pathology, molecular mechanisms and markers 96
Molecular and translational advances in meningiomas 96
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas 96
Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma 96
Ewing Sarcoma in Older Adults: A Clinicopathologic Study of 50 Cases Occurring in Patients Aged ≥40 Years, With Emphasis on Histologic Mimics 96
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance 95
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients 95
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3) 95
TERT promoter mutation: is it enough to call a WHO grade II astrocytoma IDH wild-type glioblastoma? 95
Using germline variants to estimate glioma and subtype risks 94
Cavernous Hemangiomas of the Internal Auditory Canal and Cerebellopontine Angle 94
Adenoid Cystic Carcinoma Metastatic to the Pituitary: A Case Report and Discussion of Potential Diagnostic Value of Magnetic Resonance Elastography in Pituitary Tumors 94
Totale 13.013
Categoria #
all - tutte 61.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.880 118 18 130 24 258 120 49 201 105 228 257 372
2022/20232.529 306 441 115 274 199 174 81 162 331 108 155 183
2023/2024600 41 133 36 36 66 87 49 35 20 39 44 14
2024/20253.344 52 467 230 262 659 175 227 86 55 112 156 863
2025/20267.345 465 769 760 425 754 594 713 614 1.209 407 335 300
2026/202761 61 0 0 0 0 0 0 0 0 0 0 0
Totale 18.297